Biohaven (BHVN) Cash & Current Investments (2021 - 2026)

Biohaven has reported Cash & Current Investments for 6 years, with the latest figure at $347.8 million in Q1 2026.

• Quarterly Cash & Current Investments rose 7.77% year-over-year to $347.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $347.8 million (up 7.77% YoY) and the FY2025 annual result came in at $319.1 million, down 34.33% from the prior year.
• Cash & Current Investments grew to $347.8 million in Q1 2026 per BHVN's latest filing, from $319.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $486.0 million in Q4 2024 and troughed at $23.2 million in Q2 2022.
• A 5-year average of $275.7 million and a median of $319.1 million in 2025 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 85.99% in 2022, then soared 710.15% in 2023.
• Over 5 years, Cash & Current Investments stood at $465.3 million in 2022, then declined by 17.95% to $381.8 million in 2023, then grew by 27.28% to $486.0 million in 2024, then plunged by 34.33% to $319.1 million in 2025, then advanced by 8.99% to $347.8 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $347.8 million, $319.1 million, and $260.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.